Comparison of pathologic characteristics of Tic and non-Tic cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer

World Journal of Urology

Volumn 15, Issue 6, 1997, Pages 339-345

  Hoedemaeker, Robert F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL;

AGED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0031309552     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01300181     Document Type: Article

References (18)

1. Abdel Aziz AE, Van Poppel HP, Van de Voorde WM, Van Dorpe JA, Oyen RH, Baert LV (1997) Impalpable invisible stage Tic prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens - a different view. J Urol 157: 244-250
2. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626-631
3. Auvinen A, Rietbergen JBW, Denis LJ, Schröder FH, Prorok PC (1996) Prospective evaluation plan for randomised trials of prostate cancer screening. J Med Screening 3: 97-104
4. Catalona WJ, Smith DS, RatliffTL, Dodds KM. Coplen DE, Yuan JJ, Petros JA, Andriole GL (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161
5. Catalona WJ, Smith DS, Ratliff TL, Basler JW (1993) Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954
6. Epstein Jl, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 271: 368-374
7. Geary ES, Stamey TA (1996) Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng/ml. J Urol 156: 1056-1058
8. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23: 273-279
9. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 141: 1091-1094
10. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H (1996) Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 156: 137-143
11. Montie JE, Wood DP Jr, Pontes JE, Boyett JM, Levin HS (1989) Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63: 381-385
12. Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT (1994) The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 152: 1714-1720
13. Ravery V, Boccon-Gibod LA, Meulemans A, Dauge-Geffroy MC, Toublanc M, Boccon-Gibod L (1994) Predictive value of pathological features for progression after radical prostatectomy. Eur Urol 26: 197-201
14. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In vivo 8: 439443
15. Scaletscky R, Koch MO, Eckstein CW, Bicknell SL, Gray GF Jr, Smith JA Jr (1994) Tumor volume and state in carcinoma of the prostate detected by elevations in prostate specific antigen. J Urol 152: 129-131
16. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaiuso M (1992) The TNM classification of prostate cancer. Prostate Suppl. 4: 129-138
17. Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139: 1235-1241
18. Theiss M, Wirth MP, Manseck A, Frohmuller HG (I995) Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy, Prostate 27: 1317